CD14 and head and neck squamous cell carcinoma: Likewise, in vitro treatment of whole PBMCs isolated from head and neck squamous cell carcinoma (HNSCC) patients with IFN-α2b increased the production of IL-12 in CD14+ monocytes and at the same time reduced expression of anti-inflammatory IL-4 and IL-10 (179).